Related references
Note: Only part of the references are listed.A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies
Jason T. Wiseman et al.
SURGICAL ONCOLOGY-OXFORD (2021)
Feasibility and benefits of an enhanced recovery after surgery protocol for patients undergoing cytoreductive surgery and heated intraperitoneal chemotharpy: A single institution experience
Ragavan Siddharthan et al.
AMERICAN JOURNAL OF SURGERY (2020)
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative management and special considerations
Martin Huebner et al.
EJSO (2020)
Enhanced recovery after surgery is safe for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
Robert C. G. Martin et al.
AMERICAN JOURNAL OF SURGERY (2020)
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management
Martin Hubner et al.
EJSO (2020)
Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy
Jay Tzu-Hao Huang et al.
UROLOGY (2020)
Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures
Jason M. Foster et al.
JAMA NETWORK OPEN (2019)
A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
Joel M. Baumgartner et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Alvimopan combined with enhanced recovery strategy for managing postoperative ileus after open abdominal surgery: a systematic review and meta-analysis
Liang-Liang Xu et al.
JOURNAL OF SURGICAL RESEARCH (2016)
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
Jan Franko et al.
LANCET ONCOLOGY (2016)
Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial
Cheryl T. Lee et al.
EUROPEAN UROLOGY (2014)
Evidence-based analysis of risk factors for postoperative nausea and vomiting
C. C. Apfel et al.
BRITISH JOURNAL OF ANAESTHESIA (2012)
Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer Chemotherapeutics
Csilla Hasovits et al.
CLINICAL PHARMACOKINETICS (2012)
Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Terence C. Chua et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Factors influencing early postoperative recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
E. Arakelian et al.
EJSO (2011)
Differential Effect of Hyperthermia on Nerves and Smooth Muscle of the Mouse Ileum
Shoshana Burke et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus
Gerhild Becker et al.
LANCET (2009)
Clinical trial:: alvimopan for the management of post-operative ileus after abdominal surgery:: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study
M. W. Buechler et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
Vic J. Verwaal et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Gastrointestinal Tract Recovery in Patients Undergoing Bowel Resection Results of a Randomized Trial of Alvimopan and Placebo With a Standardized Accelerated Postoperative Care Pathway
Kirk Ludwig et al.
ARCHIVES OF SURGERY (2008)
A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy
Thomas J. Herzog et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery - Results of a randomized, double-blind, controlled study
ER Viscusi et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2006)
Phase III Trial of Alvimopan, a novel, peripherally acting, Mu Opioid antagonist, for postoperative ileus after major abdominal surgery
CP Delaney et al.
DISEASES OF THE COLON & RECTUM (2005)
Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia
O Glehen et al.
LANCET ONCOLOGY (2004)
Alvimopan, a novel, peripherally acting g opioid antagonist - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus
BG Wolff et al.
ANNALS OF SURGERY (2004)
Selective postoperative inhibition of gastrointestinal opioid receptors.
A Taguchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
